Bayer Quick Ratio 2010-2025 | BAYRY

Historical quick ratio values for Bayer (BAYRY) over the last 10 years.
Bayer Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2025-03-31 $23.33B $29.46B 0.79
2024-12-31 $22.70B $31.33B 0.73
2024-09-30 $22.20B $27.54B 0.81
2024-06-30 $29.14B $33.99B 0.86
2024-03-31 $29.02B $33.26B 0.87
2023-12-31 $25.55B $31.88B 0.80
2023-09-30 $25.66B $36.01B 0.71
2023-06-30 $27.27B $35.10B 0.78
2023-03-31 $28.01B $36.92B 0.76
2022-12-31 $25.42B $36.97B 0.69
2022-09-30 $25.81B $33.41B 0.77
2022-06-30 $29.99B $35.80B 0.84
2022-03-31 $30.72B $34.81B 0.88
2021-12-31 $25.16B $34.79B 0.72
2021-09-30 $25.12B $33.88B 0.74
2021-06-30 $26.90B $33.65B 0.80
2021-03-31 $30.55B $34.88B 0.88
2020-12-31 $28.21B $41.95B 0.67
2020-09-30 $33.77B $41.84B 0.81
2020-06-30 $24.91B $40.24B 0.62
2020-03-31 $25.36B $24.62B 1.03
2019-12-31 $24.40B $26.00B 0.94
2019-09-30 $25.57B $28.98B 0.88
2019-06-30 $25.15B $28.54B 0.88
2019-03-31 $25.01B $27.14B 0.92
2018-12-31 $23.59B $26.95B 0.88
2018-09-30 $24.41B $23.48B 1.04
2018-06-30 $31.88B $31.92B 1.00
2018-03-31 $32.90B $16.10B 2.04
2017-12-31 $26.59B $15.36B 1.73
2017-09-30 $19.76B $19.60B 1.01
2017-06-30 $26.61B $20.63B 1.29
2017-03-31 $19.42B $18.57B 1.05
2016-12-31 $24.39B $20.51B 1.19
2016-09-30 $18.77B $18.61B 1.01
2016-06-30 $18.45B $19.27B 0.96
2016-03-31 $20.10B $19.23B 1.05
2015-12-31 $16.96B $18.86B 0.90
2015-09-30 $18.12B $21.52B 0.84
2015-06-30 $19.35B $22.97B 0.84
2015-03-31 $18.26B $22.87B 0.80
2014-12-31 $18.28B $20.61B 0.89
2014-09-30 $23.13B $19.58B 1.18
2014-06-30 $18.62B $20.12B 0.93
2014-03-31 $20.14B $20.95B 0.96
2013-12-31 $15.81B $18.63B 0.85
2013-09-30 $16.48B $19.54B 0.84
2013-06-30 $17.46B $19.42B 0.90
2013-03-31 $17.40B $18.19B 0.96
2012-12-31 $15.44B $16.85B 0.92
2012-09-30 $16.90B $17.19B 0.98
2012-06-30 $16.87B $17.21B 0.98
2012-03-31 $20.71B $18.54B 1.12
2011-12-31 $19.08B $18.65B 1.02
2011-09-30 $18.89B $18.71B 1.01
2011-06-30 $19.07B $19.09B 1.00
2011-03-31 $18.45B $15.33B 1.20
2010-12-31 $16.22B $14.39B 1.13
2010-09-30 $14.42B $13.13B 1.10
2010-06-30 $15.70B $15.09B 1.04
2010-03-31 $16.91B $15.41B 1.10
2009-12-31 $15.20B $12.51B 1.22
2009-09-30 $15.61B $13.14B 1.19
2009-06-30 $14.46B $12.93B 1.12
2009-03-31 $17.30B $18.32B 0.94
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $31.320B $50.438B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $722.345B 55.39
Johnson & Johnson (JNJ) United States $395.462B 16.44
AbbVie (ABBV) United States $326.520B 18.00
Novo Nordisk (NVO) Denmark $289.868B 19.21
Roche Holding AG (RHHBY) Switzerland $253.778B 0.00
Novartis AG (NVS) Switzerland $241.112B 13.06
Merck (MRK) United States $199.150B 10.18
Pfizer (PFE) United States $137.927B 7.56
Sanofi (SNY) France $117.546B 11.58
Innoviva (INVA) United States $1.224B 12.83